Neuroprotective Effect of Endogenous Pituitary Adenylate Cyclase-Activating Polypeptide on Spinal Cord Injury

[1]  M. Bracken.  Steroids for acute spinal cord injury. , 2012, The Cochrane database of systematic reviews.

[2]  M. Fehlings,et al.  Transplanted Neurally Modified Bone Marrow–Derived Mesenchymal Stem Cells Promote Tissue Protection and Locomotor Recovery in Spinal Cord Injured Rats , 2011, Neurorehabilitation and neural repair.

[3]  A. Das,et al.  Current status and prospective application of stem cell-based therapies for spinal cord injury. , 2011, Current stem cell research & therapy.

[4]  H. Vaudry,et al.  Pituitary adenylate cyclase‐activating polypeptide protects astroglial cells against oxidative stress‐induced apoptosis , 2011, Journal of neurochemistry.

[5]  R. Hashimoto,et al.  PACAP is Implicated in the Stress Axes , 2011, Current pharmaceutical design.

[6]  S. Shioda,et al.  Role of PACAP in neural stem/progenitor cell and astrocyte--from neural development to neural repair. , 2011, Current pharmaceutical design.

[7]  S. Hung,et al.  Effects of Combinatorial Treatment with Pituitary Adenylate Cyclase Activating Peptide and Human Mesenchymal Stem Cells on Spinal Cord Tissue Repair , 2010, PloS one.

[8]  H. Vaudry,et al.  Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery , 2009, Pharmacological Reviews.

[9]  S. Shioda,et al.  Role of PACAP in Ischemic Neural Death , 2008, Journal of Molecular Neuroscience.

[10]  T. Dóczi,et al.  Posttraumatic administration of pituitary adenylate cyclase activating polypeptide in central fluid percussion injury in rats , 2008, Neurotoxicity Research.

[11]  M. Endres,et al.  Pituitary adenylate cyclase‐activating polypeptide is up‐regulated in cortical pyramidal cells after focal ischemia and protects neurons from mild hypoxic/ischemic damage , 2007, Journal of neurochemistry.

[12]  H. Vaudry,et al.  Role of PACAP and VIP in astroglial functions , 2007, Peptides.

[13]  A. Deimling,et al.  Cellular localization of pituitary adenylate cyclase-activating peptide (PACAP) following traumatic brain injury in humans , 2007, Acta Neuropathologica.

[14]  O. Guntinas-Lichius,et al.  The axotomy‐induced neuropeptides galanin and pituitary adenylate cyclase‐activating peptide promote axonal sprouting of primary afferent and cranial motor neurones , 2006, The European journal of neuroscience.

[15]  Hideyuki Okano,et al.  Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury , 2006, Nature Medicine.

[16]  S. Shioda,et al.  Signaling involved in pituitary adenylate cyclase-activating polypeptide-stimulated ADNP expression , 2006, Peptides.

[17]  S. Shioda,et al.  Pleiotropic Functions of PACAP in the CNS , 2006, Annals of the New York Academy of Sciences.

[18]  Aileen J Anderson,et al.  Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. , 2006, Journal of neurotrauma.

[19]  A. Zsombok,et al.  Postinjury administration of pituitary adenylate cyclase activating polypeptide (PACAP) attenuates traumatically induced axonal injury in rats. , 2006, Journal of neurotrauma.

[20]  S. Shioda,et al.  Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Eskay,et al.  Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insult , 2005, Peptides.

[22]  S. Tzeng,et al.  Pituitary adenylate cyclase-activating polypeptide prevents cell death in the spinal cord with traumatic injury , 2005, Neuroscience Letters.

[23]  A. Zsombok,et al.  Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury , 2004, Regulatory Peptides.

[24]  D. Reglodi,et al.  Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. , 2004, Current pharmaceutical design.

[25]  F. Sundler,et al.  PACAP mRNA is expressed in rat spinal cord neurons , 2004, The Journal of comparative neurology.

[26]  S. Shioda,et al.  Expression of the receptor for pituitary adenylate cyclase-activating polypeptide (PAC1-R) in reactive astrocytes. , 2003, Brain research. Molecular brain research.

[27]  J. Takeba,et al.  Delayed neuronal damage related to microglia proliferation after mild spinal cord compression injury , 2003, Neuroscience Research.

[28]  S. Shioda,et al.  Pituitary adenylate cyclase-activating polypeptide (PACAP) prevents hippocampal neurons from apoptosis by inhibiting JNK/SAPK and p38 signal transduction pathways , 2002, Regulatory Peptides.

[29]  J. Miyazaki,et al.  Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Bradford T. Stokes,et al.  Behavioral and Histological Outcomes Following Graded Spinal Cord Contusion Injury in the C57Bl/6 Mouse , 2001, Experimental Neurology.

[31]  I. Gozes,et al.  Vasoactive Intestinal Peptide and Pituitary Adenylyl Cyclase-Activating Polypeptide Inhibit Tumor Necrosis Factor-α Production in Injured Spinal Cord and in Activated Microglia via a cAMP-Dependent Pathway , 2000, The Journal of Neuroscience.

[32]  M. Kanje,et al.  Alteration of PACAP distribution and PACAP receptor binding in the rat sensory nervous system following sciatic nerve transection , 2000, Brain Research.

[33]  L. Hillered,et al.  Regulation of pituitary adenylate cyclase activating polypeptide and its receptor type 1 after traumatic brain injury: comparison with brain-derived neurotrophic factor and the induction of neuronal cell death , 1999, Neuroscience.

[34]  T. Hökfelt,et al.  Expression of pituitary adenylate cyclase-activating polypeptide in dorsal root ganglia following axotomy: time course and coexistence , 1995, Brain Research.

[35]  D. Basso,et al.  A sensitive and reliable locomotor rating scale for open field testing in rats. , 1995, Journal of neurotrauma.

[36]  S. Shioda,et al.  Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Its Receptors: Neuroendocrine and Endocrine Interaction , 1995, Frontiers in Neuroendocrinology.

[37]  F. Sundler,et al.  Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: Immunocytochemical and immunochemical evidence , 1993, Neuroscience.

[38]  K. Mizuno,et al.  Tissue distribution of PACAP as determined by RIA: highly abundant in the rat brain and testes. , 1991, Endocrinology.

[39]  M. Culler,et al.  Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. , 1989, Biochemical and biophysical research communications.

[40]  H. Benveniste,et al.  Elevation of the Extracellular Concentrations of Glutamate and Aspartate in Rat Hippocampus During Transient Cerebral Ischemia Monitored by Intracerebral Microdialysis , 1984, Journal of neurochemistry.

[41]  A. Tamas,et al.  Mice Deficient in Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) are More Susceptible to Retinal Ischemic Injury In Vivo , 2011, Neurotoxicity Research.

[42]  H. Vaudry,et al.  Protective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) against apoptosis. , 2011, Current pharmaceutical design.

[43]  S. Shioda,et al.  Endogenous pituitary adenylate cyclase activating polypeptide is involved in suppression of edema in the ischemic brain. , 2010, Acta neurochirurgica. Supplement.

[44]  Makoto Kato,et al.  Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Stimulates Proliferation of Reactive Astrocytes In Vitro , 2010, Journal of Molecular Neuroscience.

[45]  S. Shioda,et al.  Neuroprotective Effect of PACAP Against NMDA-Induced Retinal Damage in the Mouse , 2010, Journal of Molecular Neuroscience.

[46]  S. Shioda,et al.  Pleiotropic functions of PACAP in the CNS: neuroprotection and neurodevelopment. , 2006, Annals of the New York Academy of Sciences.

[47]  N. Sherwood,et al.  The origin and function of the pituitary adenylate cyclase-activating polypeptide (PACAP)/glucagon superfamily. , 2000, Endocrine reviews.

[48]  K. Takahashi,et al.  Distribution, molecular characterization of pituitary adenylate cyclase-activating polypeptide and its precursor encoding messenger RNA in human and rat tissues. , 1993, The Journal of endocrinology.

[49]  D. Choi,et al.  The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. , 1990, Annual review of neuroscience.